AI + Synthetic Biology: The Most Transformative Technology in Human History | Ben Lamm (Colossal)

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States.

Most thematically aligned public synthetic-biology platform, but high execution and financing risk make conviction low.

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

Synthetic DNA supplier relevant to bioengineering workflows; potential picks-and-shovels exposure.

Illumina, Inc.

Sequencing infrastructure provider with indirect exposure to expanding genomics and synthetic-biology activity.

Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia.

AI-biology sentiment beneficiary, though its core business is drug discovery rather than de-extinction or biodiversity.

TMO is Thermo Fisher Scientific Inc, a Healthcare equity in the Diagnostics & Research industry.

Diversified life-science tools supplier; could benefit from broader synthetic-biology R&D spending, but impact is diluted.

Diversified life-science and diagnostics exposure; indirect picks-and-shovels beneficiary.

Brian Armstrong on Bitcoin, Anthropic Drops Fable 5 & Mythos 5, NewLimit's $435M Age-Reversal | 264 This episode is a dense Moonshots roundtable on Bitcoin, agentic payments, government stakes in AI companies, the OpenAI IPO, SpaceX’s compute expansion, Apple’s Siri reboot, and longevity biotech. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Brian Armstrong is the Co-founder and CEO of Coinbase. Salim Ismail is the founder of Open ExO, a GP at Exponential Venture Capital/The Organizational Singularity Fund and a sought after global speaker and thought leader. Apply for Salim’s Pilot Program: https://openexo.com/organizational-singularity-pilot?podcast=23.5.26 Dave Blundin is the founder & GP of Link Ventures Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified Chapters 00:00 - Intro 03:50 - BTC’s Future Outlook 15:00 - What is the Quantum BTC Risk? 20:50 - Coinbase Says the Agent Economy Has Arrived 31:30 - US government Exploring Ownership Stakes in AI Companies 45:00 - Sam Altman Meets With Sen. Bernie Sanders on 50% AI Equi

Low-coherence transcript-style text referencing: (1) a purported “global pause” by Anthropic, (2) recursive self-improvement / AI personhood themes, (3) Elon Musk/xAI deal expansion (unspecified counterpart), and (4) Argentina positioning as a global hub (compute/AI) amid opposition/regulatory capture. Most statements are non-specific, lack verifiable details (who/what/when), and provide limited direct trading catalysts.

Anthropic Files $965B IPO, Trump Signs AI Executive Order, and ChatGPT Crosses 1B Users | EP #262 In this episode, the mates discuss the Anthropic IPO filing, Trump signing the AI Executive Order, and more. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Emad Mostaque is the founder of Intelligent Internet ( https://www.ii.inc ) Dave Blundin is the founder & GP of Link Ventures Dr. Alexander Wissner-Gross is a computer scientist and founder of Reified – My companies: Apply to Dave's and my new fund: https://qr.diamandis.com/linkventureslanding Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter _ Chapters 00:00 - Anthropic's IPO and AI Market Dynamics 02:56 - US Government's AI Executive Order and National Security 05:39 - OpenAI's Rapid Growth and User Adoption 11:17 - The Future of Robotics and AI Infrastructure 14:

Ray Kurzweil on Why We’re Living in the Singularity | EP #261

Podcast discussion spans: Anthropic’s Opus 4.8 vs “GPT 5.5” narrative, OpenAI “foundation”/philanthropy, Hassabis AGI-by-2029 view, Amazon AI shopping, renewables surpassing legacy energy, AI/robots accelerating, cancer detection innovation, and social/political backlash (anti-tech extremism, UBI, workforce initiatives). Content is thematic (10+ year tech narrative) with limited concrete catalysts/tickers; best used to frame medium-term positioning in AI infrastructure, hyperscalers, robotics automation, and renewables, while noting regulatory/backlash risk to big tech.

Podcast-style, low-coherence transcript touching on (1) a major religious institution (the Vatican/Pope Leo) taking a position related to AI philosophy/AI personhood, framed as potentially aligning with EU-style caution; (2) references to frontier labs (Anthropic, xAI) and upcoming model iterations (e.g., “GPT 5.5”); and (3) a claim that Anthropic’s revenue is growing/has shifted toward a “real revenue engine,” plus a provocative/unclear claim that something “could surpass Alphabet’s total revenue,” with an isolated “$9 billion in revenu…” fragment. The entry contains some narrative signals (regulatory/ethical headwinds; frontier model progress; commercialization traction) but few verifiable, trade-ready facts.

Podcast-style discussion (fragmented transcript) about an "organizational singularity" driven by increasingly capable AI agents (AGI/ASI framing). Core idea: companies will restructure around a mission/protocol/architecture ("MTP") with agentic loops (similar to OODA/UDA loops), where agents operate via APIs, potentially changing how work is organized and how enterprise systems (ERP) are implemented/used. It references legacy enterprise stacks (Oracle Financials, SAP) and suggests SaaS/ERP vendors may be "freaked out" if agentic layers/protocols commoditize or bypass traditional ERP workflows.

The source contains only a headline with no supporting details, timing, or specifics (no confirmed filing, terms, or catalyst dates). Actionability is therefore low; at best it suggests broad themes (space/launch, AI model performance) that could map to public proxies.